NCT01105338 Lycopene or Green Tea for Men at Risk of Prostate Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01105130 L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors Status COMPLETED Phase PHASE2
NCT01098552 Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up Status COMPLETED Phase N/A
NCT01098331 Implant Radiation Therapy or Surgery in Treating Patients With Prostate Cancer Status TERMINATED Phase NA
NCT01090765 A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) Status COMPLETED Phase PHASE1/PHASE2
NCT01089881 The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer Status UNKNOWN Phase N/A
NCT01089387 Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction Status COMPLETED Phase PHASE1/PHASE2
NCT01088529 Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer Status COMPLETED Phase PHASE2
NCT01087580 Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT01087268 Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Status UNKNOWN Phase PHASE3
NCT01085422 A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE1
NCT01084759 A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer Status COMPLETED Phase NA
NCT01084655 Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01083771 Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer Status COMPLETED Phase NA
NCT01083368 Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT01079793 Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery Status WITHDRAWN Phase PHASE1/PHASE2
NCT01076335 Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer Status COMPLETED Phase PHASE2